ROIV

#573
Roivant Sciences Ltd. Common Shares
29.3935 USD
+1.53%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
29.2350
29.4200
Intervallo Annuale
18.2700
30.3300
Variazione giornaliera
+1.53%
Variazione Mensile
+3.15%
Variazione di 6 mesi
+60.53%
Variazione Annuale
+60.53%
Chiusura Precedente
28.9500
Apertura
29.3300
Bid
Ask
Minimo
29.2350
High
29.4200
Volume
310
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 21.037 B
  • Employee 750
  • Founded 2014
  • CEO Matt Gline
  • Website www.roivant.com
  • Headquarter Bermuda
  • FIGI N/A
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-42.04
Rapporto prezzo/fatturato
251.93

Roivant Sciences Ltd

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Notizie